HopeStage
Back to all studies
CompletedNCT02081287

Inositol Hexaphosphate Compared With Lamotrigine for Bipolarity

About this titleRead the official source — NCT02081287
Medication studyAges 18–75United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 75 years.

Listed locations
San DiegoSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2014
Recruitment status
Completed
Enrollment listed in the registry
8
Sponsor
San Diego Veterans Healthcare System
Sponsor type
Unknown or unclear
Study type
Drug
Intervention type
Drug
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 75 Years
Official registry ID
NCT02081287
Official title
Show the full official title

Inositol Hexaphosphate: A Novel Treatment Strategy for Bipolar Disorder?

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

San Diego

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is San Diego Veterans Healthcare System.

Did this study involve medication?

Yes. The study involved medication, including IP6 and lamotrigine.

Who was this study for?

Listed age limits: 18 years to 75 years.

Want to explore more studies?

Explore studies